rs1412829

Orientation

minus

Stabilized

minus

Make rs1412829(C;C)

Make rs1412829(C;T)

Make rs1412829(T;T)

Reference

GRCh38 38.1/141

Chromosome

9

Position

22043927

Gene	CDKN2B-AS1

is a	snp
is	mentioned by
dbSNP	rs1412829
dbSNP (classic)	rs1412829
ClinGen	rs1412829
ebi	rs1412829
HLI	rs1412829
Exac	rs1412829
Gnomad	rs1412829
Varsome	rs1412829
LitVar	rs1412829
Map	rs1412829
PheGenI	rs1412829
Biobank	rs1412829
1000 genomes	rs1412829
hgdp	rs1412829
ensembl	rs1412829
geneview	rs1412829
scholar	rs1412829
google	rs1412829
pharmgkb	rs1412829
gwascentral	rs1412829
openSNP	rs1412829
23andMe	rs1412829
SNPshot	rs1412829
SNPdbe	rs1412829
MSV3d	rs1412829
GWAS Ctlg	rs1412829

GMAF

0.2057

Max Magnitude

0

?	(C;C) (C;T) (T;T)	28

23andMe blog rs1412829 G 1.22 Glioma

GWAS snp
PMID	[PMID 19578366]
Trait	Glioma (high-grade)
Title	Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility
Risk Allele	C
P-val	2E-10
Odds Ratio	1.42 [1.27-1.58]

GWAS snp
PMID	[PMID 20512145]
Trait	Nasopharyngeal carcinoma
Title	A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci.
Risk Allele
P-val	5E-7
Odds Ratio	1.28 [1.18-1.41]

OMIM	607107
Desc
Variant
Related	also

OMIM	613030
Desc
Variant
Related	also

[PMID 18426861] Association analysis of type 2 diabetes Loci in type 1 diabetes.

[PMID 18694974] Predicting type 2 diabetes based on polymorphisms from genome-wide association studies: a population-based study.

[PMID 19341491] Genome-based prediction of common diseases: methodological considerations for future research.

[PMID 20212223] New insights into susceptibility to glioma.

[PMID 21278902] Genetic risk profiling for prediction of type 2 diabetes.

[PMID 26014354] CCDC26, CDKN2BAS, RTEL1 and TERT Polymorphisms in pediatric brain tumor susceptibility

[PMID 26839018] Genetic risk variants in the CDKN2A/B, RTEL1 and EGFR genes are associated with somatic biomarkers in glioma.

[PMID 27517745] Nasopharyngeal carcinoma risk prediction via salivary detection of host and Epstein-Barr virus genetic variants.